İnsan çevirisi örneklerinden çeviri yapmayı öğrenmeye çalışıyor.
Profesyonel çevirmenler, işletmeler, web sayfaları ve erişimin serbest olduğu çeviri havuzlarından.
aldosterona antagonisti,.
aldosterone antagonist.
Son Güncelleme: 2012-04-10
Kullanım Sıklığı: 2
Kalite:
farmakoterapeitiskā grupa: aldosterona antagonisti.
pharmacotherapeutic group: aldosterone antagonist.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
telmisartāns pazemina aldosterona līmeni plazmā.
plasma aldosterone levels are decreased by telmisartan.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
aktivēta renīna-angiotensīna-aldosterona sistēma
activated renin-angiotensin-aldosterone system
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
zycortal lieto ilgtermiņā trūkstošā aldosterona aizstāšanai.
zycortal is used long-term to replace the missing aldosterone.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
divkārša renīna-angiotenzīna-aldosterona sistēmas blokāde
dual blockade of the renin-angiotensin-aldosterone system
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
kardiovaskulārajā sistēmā spironolaktons profilaktē aldosterona nevēlamo ietekmi.
in the cardiovascular system, spironolactone prevents the detrimental effects of aldosterone.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
Ārstēšanas laikā var novērot nelielu aldosterona līmeni asinīs.
a slight increase in aldosterone blood levels may be observed in animals on treatment.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
citi stāvokļi ar aktivizētu renīna-angiotenzīna-aldosterona sistēmu
other conditions with stimulation of the renin-angiotensin-aldosterone system
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
citi stāvokļi, kad aktivizēta renīna-angiotenzīna-aldosterona sistēma
other conditions with stimulation of the renin-angiotensin-aldosterone system
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
sirds-asinsvadu sistēmā spironolaktons aizkavē kaitīgo aldosterona ietekmi.
in the cardiovascular system, spironolactone prevents the detrimental effects of aldosterone.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
aldosterona deficīts var izraisīt šķidrumu zudumu, dehidratāciju un svara zudumu.
the lack of aldosterone can cause fluid loss, dehydration and weight loss.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
bloķējot aldosterona iedarbību, spironolaktons palielina sāļu un ūdens izdalīšanos ar urīnu.
by blocking aldosterone, spironolactone increases the elimination of salt and water in the urine.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
aldosterona sekrēciju veicina ne tikai angiotenzīns ii, bet arī k+ pieaugums un akth.
secretion of aldosterone can also be stimulated by factors other than angiotensin-ii, notably k+ increase or acth.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
Šāda iedarbība ir konstatēta arī citiem renīna-angiotensīna-aldosterona sistēmas inhibitoriem.
this effect is also seen with other inhibitors of the renin-angiotensin-aldosterone system.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
zāļu, kas ietekmē renīna-angiotenzīna-aldosterona sistēmu, lietošana var izraisīt hiperkaliēmiju.
the use of medicinal products that affect the renin-angiotensin-aldosterone system may cause hyperkalaemia.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
lietojot kombinācijā ar ace-inhibitoriem, spironolaktons var darboties pret „aldosterona noplūdes” efektu.
when used in combination with ace-inhibitors, spironolactone may counteract the effects of “aldosterone escape”.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
paaugstināts aldosterona līmenis (ūdens un sāls aizture organismā, kopā ar dažādu minerālvielu disbalansu asinīs).
raised aldosterone levels (water and salt retention in the body along with imbalance of various blood minerals).
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
pirms vienlaicīgas renīna-angiotenzīna-aldosterona sistēmu ietekmējošu zāļu lietošanas apsvēršanas jānovērtē ieguvuma un riska attiecība.
before considering the concomitant use of medicinal products that affect the renin-angiotensin- aldosterone system, the benefit risk ratio should be evaluated.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 4
Kalite:
selektīvs antagonisms pret angiotensīna ii (at1) receptoriem paaugstina renīna un angiotensīna ii līmeni plazmā un mazina aldosterona koncentrāciju plazmā.
the selective antagonism of the angiotensin-ii (at1) receptors results in increases in plasma renin levels and angiotensin-ii levels, and a decrease in plasma aldosterone concentration.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 5
Kalite: